Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4208122
Max Phase: Preclinical
Molecular Formula: C47H63N9O11
Molecular Weight: 930.07
Molecule Type: Small molecule
Associated Items:
ID: ALA4208122
Max Phase: Preclinical
Molecular Formula: C47H63N9O11
Molecular Weight: 930.07
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](N)C(=O)OCCN(C)/[N+]([O-])=N/Oc1cc(N2CCN(C(=O)[C@]34CCC(C)(C)C[C@H]3[C@H]3C(=O)C=C5[C@@]6(C)C=C(C#N)C(=O)C(C)(C)[C@@H]6CC[C@@]5(C)[C@]3(C)CC4)CC2)c([N+](=O)[O-])cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C47H63N9O11/c1-28(49)40(59)66-21-20-51(9)56(65)50-67-35-23-31(32(54(61)62)22-33(35)55(63)64)52-16-18-53(19-17-52)41(60)47-14-12-42(2,3)26-30(47)38-34(57)24-37-44(6)25-29(27-48)39(58)43(4,5)36(44)10-11-45(37,7)46(38,8)13-15-47/h22-25,28,30,36,38H,10-21,26,49H2,1-9H3/b56-50-/t28-,30-,36-,38-,44-,45+,46+,47-/m0/s1
Standard InChI Key: PVFPSXUEANDVSC-PRNNQJOESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 930.07 | Molecular Weight (Monoisotopic): 929.4647 | AlogP: 6.36 | #Rotatable Bonds: 11 |
Polar Surface Area: 270.98 | Molecular Species: ACID | HBA: 15 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.11 | CX Basic pKa: 7.34 | CX LogP: 3.51 | CX LogD: 5.50 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.08 | Np Likeness Score: 0.61 |
1. Kang F, Ai Y, Zhang Y, Huang Z.. (2018) Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O2-(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer., 149 [PMID:29501947] [10.1016/j.ejmech.2018.02.062] |
Source(1):